Kiboi D, Sa J, Nayak A, Micchelli C, Amin S, Burbelo A
Antimicrob Agents Chemother. 2025; 69(3):e0005324.
PMID: 39927767
PMC: 11881564.
DOI: 10.1128/aac.00053-24.
Basco L
Pathogens. 2023; 12(7).
PMID: 37513747
PMC: 10384318.
DOI: 10.3390/pathogens12070900.
Mohapatra A, Zuromski J, Kurtis J
Methods Mol Biol. 2022; 2470:659-672.
PMID: 35881381
DOI: 10.1007/978-1-0716-2189-9_49.
Raj D, Mohapatra A, Jnawali A, Zuromski J, Jha A, Cham-Kpu G
Nature. 2020; 582(7810):104-108.
PMID: 32427965
PMC: 7372601.
DOI: 10.1038/s41586-020-2220-1.
Tixeira R, Poon I
Cell Mol Life Sci. 2018; 76(2):245-257.
PMID: 30317529
PMC: 11105331.
DOI: 10.1007/s00018-018-2932-7.
Wanted , dead or alive.
Sow F, Nyonda M, Bienvenu A, Picot S
Microb Cell. 2017; 2(7):219-224.
PMID: 28357297
PMC: 5349169.
DOI: 10.15698/mic2015.07.211.
Cell death in parasitic protozoa: regulated or incidental?.
Proto W, Coombs G, Mottram J
Nat Rev Microbiol. 2012; 11(1):58-66.
PMID: 23202528
DOI: 10.1038/nrmicro2929.
On Programmed Cell Death in Plasmodium falciparum: Status Quo.
Engelbrecht D, Durand P, Coetzer T
J Trop Med. 2012; 2012:646534.
PMID: 22287973
PMC: 3263642.
DOI: 10.1155/2012/646534.
Investigating the evolution of apoptosis in malaria parasites: the importance of ecology.
Pollitt L, Colegrave N, Khan S, Sajid M, Reece S
Parasit Vectors. 2010; 3:105.
PMID: 21080937
PMC: 3136143.
DOI: 10.1186/1756-3305-3-105.
Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial.
Thompson F, Porter D, Okitsu S, Westerfeld N, Vogel D, Todryk S
PLoS One. 2008; 3(1):e1493.
PMID: 18231580
PMC: 2204057.
DOI: 10.1371/journal.pone.0001493.
Killing of Plasmodium yoelii by enzyme-induced products of the oxidative burst.
Dockrell H, Playfair J
Infect Immun. 1984; 43(2):451-6.
PMID: 6546375
PMC: 264315.
DOI: 10.1128/iai.43.2.451-456.1984.
African serum interference in the determination of chloroquine sensitivity in Plasmodium falciparum.
Carlin J, vande Waa J, Jensen J, Akood M
Z Parasitenkd. 1984; 70(5):589-97.
PMID: 6391006
DOI: 10.1007/BF00926589.
Longitudinal study on the in vitro immune response to Plasmodium falciparum in Sudan.
vande Waa J, Jensen J, Akood M, Bayoumi R
Infect Immun. 1984; 45(2):505-10.
PMID: 6378799
PMC: 263274.
DOI: 10.1128/iai.45.2.505-510.1984.
Comparison of immunity to malaria in Sudan and Indonesia: crisis-form versus merozoite-invasion inhibition.
Jensen J, Hoffman S, Boland M, Akood M, Laughlin L, Kurniawan L
Proc Natl Acad Sci U S A. 1984; 81(3):922-5.
PMID: 6366793
PMC: 344951.
DOI: 10.1073/pnas.81.3.922.
Serum containing tumor necrosis factor is cytotoxic for the human malaria parasite Plasmodium falciparum.
Haidaris C, Haynes J, Meltzer M, Allison A
Infect Immun. 1983; 42(1):385-93.
PMID: 6352501
PMC: 264569.
DOI: 10.1128/iai.42.1.385-393.1983.
Association between human serum-induced crisis forms in cultured Plasmodium falciparum and clinical immunity to malaria in Sudan.
Jensen J, Boland M, Allan J, Carlin J, vande Waa J, Divo A
Infect Immun. 1983; 41(3):1302-11.
PMID: 6350183
PMC: 264640.
DOI: 10.1128/iai.41.3.1302-1311.1983.
Plasmodium falciparum: invasion and development in highly parasitized cultures.
Raventos-Suarez C
In Vitro Cell Dev Biol. 1985; 21(3 Pt 1):161-4.
PMID: 3891720
DOI: 10.1007/BF02621353.
Inhibition of malaria parasite invasion of human erythrocytes by a lymphocyte membrane polypeptide.
Milner Y, Ginsburg H
Infect Immun. 1987; 55(2):342-51.
PMID: 3542831
PMC: 260332.
DOI: 10.1128/iai.55.2.342-351.1987.
Tumor necrosis factor does not induce Plasmodium falciparum crisis forms.
Jensen J, vande Waa J, Karadsheh A
Infect Immun. 1987; 55(7):1722-4.
PMID: 3298067
PMC: 260585.
DOI: 10.1128/iai.55.7.1722-1724.1987.
Plasmodium chabaudi malaria: protective immunization with surface membranes of infected erythrocytes.
Wunderlich F, BRENNER H, Helwig M
Infect Immun. 1988; 56(12):3326-8.
PMID: 3182084
PMC: 259746.
DOI: 10.1128/iai.56.12.3326-3328.1988.